Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1056279

Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori


Bago, Josip; Halle, Željka; Bakula, Vinko; Perić, Rosana; Marusic, Marinko; Luetic, Kresimir; Jurcic, Dragan; Bilic, Ante; Dominkovic, Anto
Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori // Journal of gastroenterology and hepatology, 28 (2013), 545-546 (međunarodna recenzija, ostalo, znanstveni)


CROSBI ID: 1056279 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori

Autori
Bago, Josip ; Halle, Željka ; Bakula, Vinko ; Perić, Rosana ; Marusic, Marinko ; Luetic, Kresimir ; Jurcic, Dragan ; Bilic, Ante ; Dominkovic, Anto

Izvornik
Journal of gastroenterology and hepatology (0815-9319) 28 (2013); 545-546

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, ostalo, znanstveni

Ključne riječi
Helicobacter pylori, moxifloxacin, sequential therapy

Sažetak
The efficacy of moxifloxacin based triple therapy vs sequential therapy as a second line treatment is presented in this work.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinička bolnica "Sveti Duh",
Medicinski fakultet, Osijek


Citiraj ovu publikaciju:

Bago, Josip; Halle, Željka; Bakula, Vinko; Perić, Rosana; Marusic, Marinko; Luetic, Kresimir; Jurcic, Dragan; Bilic, Ante; Dominkovic, Anto
Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori // Journal of gastroenterology and hepatology, 28 (2013), 545-546 (međunarodna recenzija, ostalo, znanstveni)
Bago, J., Halle, Ž., Bakula, V., Perić, R., Marusic, M., Luetic, K., Jurcic, D., Bilic, A. & Dominkovic, A. (2013) Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori. Journal of gastroenterology and hepatology, 28, 545-546.
@article{article, author = {Bago, Josip and Halle, \v{Z}eljka and Bakula, Vinko and Peri\'{c}, Rosana and Marusic, Marinko and Luetic, Kresimir and Jurcic, Dragan and Bilic, Ante and Dominkovic, Anto}, year = {2013}, pages = {545-546}, keywords = {Helicobacter pylori, moxifloxacin, sequential therapy}, journal = {Journal of gastroenterology and hepatology}, volume = {28}, issn = {0815-9319}, title = {Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori}, keyword = {Helicobacter pylori, moxifloxacin, sequential therapy} }
@article{article, author = {Bago, Josip and Halle, \v{Z}eljka and Bakula, Vinko and Peri\'{c}, Rosana and Marusic, Marinko and Luetic, Kresimir and Jurcic, Dragan and Bilic, Ante and Dominkovic, Anto}, year = {2013}, pages = {545-546}, keywords = {Helicobacter pylori, moxifloxacin, sequential therapy}, journal = {Journal of gastroenterology and hepatology}, volume = {28}, issn = {0815-9319}, title = {Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori}, keyword = {Helicobacter pylori, moxifloxacin, sequential therapy} }




Contrast
Increase Font
Decrease Font
Dyslexic Font